Drug Search Results

Gabexate

Alternative Names: gabexate
Latest Update: 2024-05-07
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: SP Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Korea | Taiwan | Ukraine

Approved Indications: None

Known Adverse Events: None

Company: Yonsei University
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Gabexate

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Sepsis|Reperfusion Injury|Hepatocellular Carcinoma|Small Cell Carcinoma|Liver Failure, Acute

Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success
ChiCTR-IPR-14005518	N/A	Not yet recruiting	Pancreatitis, Acute	2017-12-31
NCT02710266	P3	Terminated	Small Cell Carcinoma\|Liver Failure, Acute\|Sepsis\|Hepatocellular Carcinoma\|Reperfusion Injury	2017-02-25

Recent News Events

Date	Type	Title
05/07/2024	PubMed	Inflammation and Acinar Cell Dual-Targeting Nanomedicines for Synergistic Treatment of Acute Pancreatitis via Ca2+ Homeostasis Regulation and Pancreas Autodigestion Inhibition.
03/15/2024	PubMed	Involvement of peripheral mast cells in a fibromyalgia model in mice.
10/27/2023	PubMed	Mechanisms of NMDA Receptor Inhibition by Sepimostat-Comparison with Nafamostat and Diarylamidine Compounds.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions